chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx 8 hours after injection I suddenly became slightly dizzy and had moderate nausea.  I also became very tired and fell asleep for about 1.5 hrs even though I was well rested.  For the remainder of the night of 5 Jan and all day on 6 Jan I was fatigued and had moderate injection site pain.  On  7 Jan, I felt much better (no fatigue or injection site pain) but had a very hard time mentally focusing.  All symptoms resolved by the night of 7 Jan and as of 8 Jan feel normal.
Urticaria that started about 10 days after the booster dose on 1/6/2022 and is ongoing as of today (2/5/2022)
ON 3/12/2021 I received vaccine at 12:15 pm.  After it was administered I waited 15 minutes to see if I got an reaction to it.  I was fine until about 3:00pm in the afternoon that I started  to feel fatigue, body aches, also had chest pains on left side and in shoulder.  pain stayed rest of the night. subsided on Saturday and returned on Sunday. Went to Hospital Sunday Night qround 7:00pm to get heart check out.
Pt. felt "bad" all weekend after shot. Whole arm red and swollen. Blisters on bottom lip.
The patient was given the wrong vaccine. She was due for DTaP, but she received Tdap, by accident. Provider spoke with CDC, who verified that this dose is considered "valid".
blood clot stroke\heart went into a fib; blood clot stroke; lost 20 pounds; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergic to milk" (unspecified if ongoing), notes: allergic to milk. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number:01), for Covid-19 Immunization. The following information was reported: THROMBOSIS (hospitalization, medically significant) with onset 21Mar2021, outcome "recovering", described as "blood clot stroke\heart went into a fib"; CEREBROVASCULAR ACCIDENT (hospitalization, medically significant) with onset 21Mar2021, outcome "recovering", described as "blood clot stroke"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "lost 20 pounds". The patient was hospitalized for thrombosis, cerebrovascular accident (hospitalization duration: 2 day(s)). The events "blood clot stroke\heart went into a fib", "blood clot stroke" and "lost 20 pounds" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: cardiac stress test: passed; computerised tomogram: blood clot stroke, notes: blood clot stroke, The stroke was in the lower part of his brain.Head CT; investigation: results unknown. Therapeutic measures were taken as a result of thrombosis, cerebrovascular accident. Clinical course: The caller is calling about the Pfizer covid shot. 3 weeks after the shot the caller got a blood clot stroke, he had to go to the emergency room, and had an emergency procedure to get the clot out of his brain.The caller lost 20 pounds since this event.The caller feels better now and was healthy prior to taking the vaccine. The caller was in the hospital for 2 days. The caller was sitting on the couch and couldn't get up, he didn't look good. They called the EMS and took the caller to the hospital that handles strokes. They did a CAT scan on the callers head and saw that he was having a stroke. They went in through his penis for his procedure to get the clot. The stroke was in the lower part of his brain. The caller went to a neurologist and did tests and then the cardiologist had him do a test on the heart because his heart went into a fib, which he has never had before. This has settled down now. They made him do a nuclear stress test which the caller passed. Then because of the stroke the caller was put on meds that made all sorts of weird things happen to him. Patient did not have risk factors for TTS or other relevant medical history. He did not receive concomitant medications within 2 weeks of event onset. Patient received Blood clot retrieval in brain for TTS.    The lot number for bnt162b2 was not provided and will be requested during follow up.
PATIENT CAME IN ON 02/25/2022 COMPLAINING OF A SORE ARM. UPON INSPECTING THE ARM, I NOTICED RED RAISED POSTULES GOING UP THE ARM BY THE SHOULDER THAT LOOKED LIKE SHINGLES. I ADVISED PATIENT TO SEEK MEDICAL ATTENTION.
Very painful at injection site for 3 days.  Fatigue, body aches, chills for approximately 12 hours the following day
Information has been received from a health professional a female who was vaccinated with Gardasil. Subsequently the patient experienced pain, throbbing, stinging, burning sensation and passed out after receiving vaccination. Medical attention was sought.  Subsequently, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
Dizziness and nausea vomiting. Ondansetron 4 mg PRN, meclizine 12.5 mg PRN, prochlorperazine 10 mg PRN.
TSH increased from 6.0 to 29 in a matter of a month after receiving the COVID vaccine series
Information has been received from a nurse concerning a female (age not reported) who on 29-NOV-2007 was vaccinated (route and site not reported) with the 2nd dose of Gardasil (lot# not reported).  On 29-NOV-2007, post vaccination, the patient experienced tingling and numbness at injection site, in her fingertips and toes and she felt shaky.  The patient did not have this experience with the 1st dose (date unknown).  The patient did receive unspecified medical attention.  At the time of this report the patient had not recovered.  Additional information has been requested.
Information has been received from a physician, via a company representative, concerning a female patient, who was vaccinated (date not specified) with a dose of Gardasil. Right after the shot was administered, the patient experienced "more than moderate itching" at the injection site. At the time of this report, the physician reported that the patient was recovering. The patient sought unspecified medical attention. The patient's two sisters also experienced the event as described above after vaccination with Gardasil (WAES0703USA04922,0703USA05148). Additional information has been requested.
Day after the vaccine developed some pain in left axilla, left anterior shoulder, and left chest.  No redness, warmth. Afebrile. Did have slight decrease in ROM. General malaise, congestion, developed emesis two days afterwards. Also had rash in left armpit. Pain resolved within 2 days and had no further issues. Unclear if vaccine related.
first dose middle of January never got second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose middle of January never got second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose middle of January never got second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose middle of January never got second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Left deltoid red, swollen, stomach ache, RX'd Keflex could not exclude cellulitis.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a 68-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included hypertension. In June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever, myalgia, shivering, headache, feeling down, erythema, tenderness and swelling. On an unknown date, the outcome of the influenza-like symptoms, fever, myalgia, shivering and headache were unknown and the outcome of the feeling down, erythema, tenderness and swelling were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, fever, myalgia, shivering, headache, feeling down, erythema, tenderness and swelling to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, but it could be 67 or 68 years. The patient received 1st dose at retail and not at the reporting nurse's clinic. The exact date of vaccination was not reported. The patient experienced flu like symptoms consisting of fever, myalgia, shivering and headache and was being down for a week. The patient also experienced local redness, tenderness and swelling lasting a few days. The nurse did not agree to follow up from GlaxoSmithKline. This case has been linked with the case US2018GSK139588, reported for patient's wife.
REDNESS, ITCHING, AND SWOLLEN AT THE INJECTION SITE, AND LOCAL AREA (ARM).  THIS HAS IMPROVED OVER TIME WITHOUT ANY TREATMENT NECESSARY.
TOOK UNREFRIGERATED DOSES; This spontaneous case (PVX2019-1132) was received from a pharmacist on 07-May-2019. It describes a male consumer who "took unrefrigerated doses". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took 3 unrefrigerated doses of Vivotif.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "took unrefrigerated doses" was unknown.  Company's Comment: The causality of the event "took unrefrigerated doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took unrefrigerated doses" was considered as not applicable.
Information has been received from a physician concerning her daughter, a 19 year old female who on 13-OCT-2006 was vaccinated with the first dose of Gardasil vaccine (yeast) (lot#653938/0954F) without any difficulties. On 02-JAN-2007 the patient received the second dose of Gardasil vaccine (yeast) (lot#654389/0961F). Concomitant therapy included fluoxetine HCl (SARAFEM) and "Femcon" (NOS). On approximately 06-JAN-2007 the patient developed a tender reddened firm area in her upper arm around the injection site that "hurt her to sleep on". On an unspecified date the patient went to the emergency room and was diagnosed with cellulitis and treated with Cephalexin (Keflex). After 10 days of treatment with cephalexin was completed the patient's "reddened firm area went down and was less tender". However, with 48 hours of stopping the therapy with cephalexin the area was "reddened, firm and tender". After 5 days the patient was seen at her university health services office, who "refused to treat her for cellulitis and referred her back to her gynecologist who gave her the vaccine". On approximately 01-FEB-2007 the patient was then seen by the internist who diagnosed her with a hematoma. At the time of this report the cellulitis was considered resolved and the hematoma was resolving. The physician reported that the patient will continue with the third vaccination in her other arm. The reporting physician consider the cellulitis to be a serious other medical event. Additional information has been requested.
Associate reported to Occ Health to inform that she had felt "a tingling/numbing sensation and heaviness to my arm soon after receiving the injection. I think that maybe the fluid went into the tissue and not to the muscle but I got busy because I had to report to the center for the drill and so I never came back. As the day progressed I just didn't feel right. The heaviness is what bothered me the most. I asked my husband to look at it last night and he said that he could see it. I noticed it red and indurated and today it feels warm."  The Associate does not report a fever or other S&S of malaise.  Observed left deltoid area with erythema, induration and warmth around area of erythema. Site is ~5.5 cm x 6/5 cm in diameter. Associate verbalized concern about "cellulitis at site." The Associate reports that she "has had cellulitis to her ankle before."  Read over possible side effects from CDC. Advised Associate if concerned about possible infection to seek a consultation with her PCP especially if no improvement of worsening of S&S. The Associate states that "she feels it is better today than last night." Advised to take Ibuprofen (unless medically contra-indicated) for pain, discomfort and as an anti-inflammatory and for comfort she may cold compresses as needed and to report to office on Monday for follow-up. The Associate stated that she "was going to try to be seen in the Employee Health Clinic today."
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 62-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of pain in extremity (After receiving 1st dose on 20th August 2018, refer case US2018218442). On 30th November 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced pain in arm. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The reporter was the patient's husband. The patient received SHINGRIX in the left arm. The patient experienced left arm pain. The reporter gave consent for follow up. The physician contact details were provided.
Immunizations were drawn up by a medical assistant that I work with and I went to assist in administering the immunizations. Administration of vaccincations without difficulty. Realized after administration that Hepatitis B was given instead of Hib that was supposed to be administered.
Administered IM flu shot to pt in left deltoid. Pt bled a bit, so removed the sticker and placed a cotton ball on site to apply pressure and stop the bleeding, which it did. Put a regular band-aid on site and began to notice some swelling about the band-aid area. Had technician get an ice pack and had pt apply that to area while we administered 2 IMZ's to her husband. Area was still swollen after several minutes. Gave pt one 25 mg diphenhydramine to take, cautioning drowsiness. Pt said she was feeling fine, but just had the swelling in the arm. We gave her a VIS form and a copy of the exact strains in the Afluria. She said she had gotten flu shots before, but not at this location, so not sure which brand she had in the past. She said she wasn't allergic to eggs or anything else that she was aware of. Tried to call pt that evening to check on her and again the next day, but had not yet heard back from pt.
Uticaria to R upper chest welt 3 cm raised macule + dermatographism benadryl given PO - will give benadryl + MMR -> #2.
Vaccine remained in the freezer past the recommended guidelines (14 days). Once discovered, Pfizer was contacted but did not have stability data to support acceptability of the product greater than 31 days in the freezer. All patients that were administered vaccine past 31 days were contacted and given an option to be re-vaccinated based on their doctor'S recommendation advisory guidance.
After a half hour of receiving the vaccine, I experienced redness and swelling in the injection site, flushing on my forehead and nose, and itching all over my body. I took a 25mg dose of Benadryl and the hospital monitored my vital signs for about an hour afterwards. I had a fever on the second day (2/06/2021) but it only lasted about 5 hours. However, I have had constant systemic itching everyday. I take 25mg Benadryl but today, 2/09/21, it has been more intense. Please note that I had no reaction to the first dose besides a sore arm for three days.  I am very concerned about the itching and it is making it difficulty for me to sleep and also to do my daily activities.
Pt developed chickenpox on 5/16/2006. Was vaccinated by another provider on 11/2/2000 with varicella vaccine.
Intermittent menstrual spotting; Late period; Cramping; Large menstrual clot; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Apr2021 at 12:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. It was not known if the patient was pregnant. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), gabapentin (MANUFACTURER UNKNOWN) and sertraline hydrochloride (ZOLOFT); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021, the patient experienced intermittent menstrual spotting, late period, large menstrual clot and cramping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intermittent menstrual spotting, late period, large menstrual clot and cramping was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain to Rt. upper arm shoulder and elbow joints shot was given in the rt arm. Swelling to the whole upper arm with a developed rash approximately 7-9 cm, the rash area has developed a small blister also warm to touch. Lastly frequent headaches. I have been putting ice, hydro-cortisone cream, and taking Mobic.
Aching; chills; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunisation .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced aching and chills on Jan2021.  The outcome of events was unknown.  Information on the lot/batch number has been requested.
Developed generalized pruritis without any rash while driving home about one hour after vaccination.  Symptoms resolved over one week.  Received H1N1 vaccine 11/16/2009.  Developed generalized pruritis without rash one hour later.  Pruritis continued until seen by me on 12/14/2009.  Has seen primary care physician who treated her for a yeast infection and provided Lidex.  Unknown if pruritis is related to flu vaccine, or to other medical conditions.  This is a possibly vaccine related condition, but more than likely not related.  The patient was referred back to her own primary care provider.
Pt received Fluzone HD at 5pm and around 9:30pm starting complaining of burning sensation in throat and sore throat. Pt had diarrhea, nausea and vomiting and went to ER where they gave her a IV for dehydration. Pt was disharged later that evening.
Employee received Flu Vaccine and reports to me that 1 hour later c/o throat tightness, severe Rt arm pain and dysphagia. Took a Benadryl 50mg and in 20 minutes tells me her symptoms were gone. She did not seek Medical Intervention.
5 days after vaccine administration developed raised red rash about 2 inches in diameter. Also axillary lymphadenopathy
Triaged pt. (took vitals) then administered CERVARIX to (L) arm. Pt. was sitting at the time of shot. Pt. indicated her fear of needles so I instructed her to look away and stay seated. Once given I proceeded to fill out physical form. Pt. got dizzy and fell over about a minute after given. Vitals were taken and pt. was released once vitals were normal and Dr. released. Pt. did not fully pass out. Got dizzy and fell down.
Initially the patient developed low grade fevers and "brain fog" immediately after the first Moderna COVID-19 Vaccination. The patient developed extreme weakness, dizziness, numbness, and worsening cognitive changes after the second COVID -9 Moderna Vaccination.  Now complains of increasing sexual dysfunction.  Dizziness and numbness have improved but still present.  Cognitive changes still present but also improved.
Pt came in 10/27/11 pain on (Lt) upper arm. Pt was prescribed hydroxyzine 25mg, KEFLEX 500mg, Ibuprofen 800mg & warm compressions. F/U 11/5/11 facial numbness prescribed prednisone 10mg.
Patient was feeling light headache and sweaty after 15 minutes of the Pfizer shot. He fainted and felt on the floor. His legs were elevated after 10 seconds he was fine and refused to have any kind of medical treatments.  After 30 minutes of observation he was alert, happy and left.
I was positive for COVID-19 on 26NOV2023, I thought I had a flu but when we tested we were positive. I had stuffy head, congested and I wasn't feeling good. I don't remember all the symptoms but they were all mild just as if I had a flue.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 15-JUN-2017, the patient was vaccinated with a dose of ZOSTAVAX as prophylaxis (Strength, dose, route, lot # and expiration date were not reported), which was reconstituted with another company sterile diluent (Strength, dose, route, lot # and expiration date were not reported). No adverse effects were reported.
Within minutes of receiving the vaccine (I was on the phone at the time and noted that my left inner wrist felt internally hot). My left arm from injection to fingertips felt internally as if I was injected with peppermint oil. A hot/overly cold prickly feeling started and then proceeded to feel hotter and my arm felt tingly, numb, as if an epidural was put on my left arm or it fell asleep. These feelings were internal (no rash or external redness). I also felt a bit of this same on my lower left jaw (again no outside rash or redness just inside feeling). I reported it immediately to the pharmacist who administered the shot and he said there looks to be no redness and that after my 15 minutes was up it was ok to go home. It is 5 hours now after the shot and it feels as if a nerve has been hit - my arm feels very internally cold. Fingers and arm functions fine, but it feels like its slightly detached from myself (none of this occurs anywhere other than the injection site down to fingertips and left jaw bone).
Most unusual event was tinnitus and vertigo about 3 or 4 hours after injection.  Lasted for about 5 minutes though was the worst for about a minute then got better.  Others are more typical, sore arm, nausea for about the first 2 hours after injection, slight chills no fever, a little achy, feeling very fatigued for 2 days.  Generally feeling off but never really bad.
pt recv vax 17SEP98 & 18SEP98 around 12oclock pt devel hives;no further sx noted;seen by medical provider;
sore, warm, red, bruised spot on the left arm at injection site.  Prednisone given orally.